A carregar...
Does a mandatory non-medical switch from originator to biosimilar infliximab lead to increased use of outpatient healthcare resources? A register-based study in patients with inflammatory arthritis
OBJECTIVES: National Danish guidelines in May 2015 dictated a mandatory switch from originator infliximab (INX) to biosimilar CT-P13 in patients with inflammatory rheumatic disease. We investigated if this non-medical switch changed use of outpatient hospital resources. METHODS: Observational cohort...
Na minha lista:
| Publicado no: | RMD Open |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6045751/ https://ncbi.nlm.nih.gov/pubmed/30018807 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2018-000710 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|